Immuneering (IMRX) Interest & Investment Income (2020 - 2023)
Historic Interest & Investment Income for Immuneering (IMRX) over the last 4 years, with Q4 2023 value amounting to $754144.0.
- Immuneering's Interest & Investment Income rose 4610.44% to $754144.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.6 million, marking a year-over-year increase of 25555.9%. This contributed to the annual value of $3.6 million for FY2023, which is 25555.96% up from last year.
- According to the latest figures from Q4 2023, Immuneering's Interest & Investment Income is $754144.0, which was up 4610.44% from $855532.0 recorded in Q3 2023.
- Over the past 5 years, Immuneering's Interest & Investment Income peaked at $1.2 million during Q2 2023, and registered a low of $518.0 during Q4 2020.
- Its 4-year average for Interest & Investment Income is $319699.3, with a median of $142799.0 in 2022.
- Over the last 5 years, Immuneering's Interest & Investment Income had its largest YoY gain of 2748397.68% in 2021, and its largest YoY loss of 3205.02% in 2021.
- Over the past 4 years, Immuneering's Interest & Investment Income (Quarter) stood at $518.0 in 2020, then skyrocketed by 27483.98% to $142885.0 in 2021, then skyrocketed by 261.25% to $516168.0 in 2022, then skyrocketed by 46.1% to $754144.0 in 2023.
- Its Interest & Investment Income stands at $754144.0 for Q4 2023, versus $855532.0 for Q3 2023 and $1.2 million for Q2 2023.